Innoviva (INVA) Interest Expenses (2010 - 2026)
Innoviva (INVA) posted Interest Expenses of $26.6 million for Q1 2026, up 713.7% on a QoQ basis from $3.3 million in Q4 2025, and up 1.14% year-over-year from $26.3 million in Q1 2025.
Innoviva (INVA) Interest Expenses (2010 - 2026) Analysis & Trends
Innoviva's Interest Expenses history runs 17 years deep, the most recent figure standing at $26.6 million for Q1 2026.
- Quarterly Interest Expenses rose 1.14% year-over-year to $26.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.6 million (up 1.14% YoY) and the FY2025 annual result came in at $49.2 million, down 73.78% from the prior year.
- Interest Expenses was $26.6 million for Q1 2026 at Innoviva, up from $3.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $169.2 million in Q4 2023 and bottomed at $3.3 million in Q4 2025.
- A 5-year average of $24.7 million and a median of $15.4 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses jumped 2935.86% — and 2024, when it plunged 97.05%.
- Innoviva's Interest Expenses stood at $5.6 million in 2022, then soared by 2935.86% to $169.2 million in 2023, then plunged by 97.05% to $5.0 million in 2024, then plunged by 34.62% to $3.3 million in 2025, then jumped by 713.7% to $26.6 million in 2026.
- Business Quant data shows INVA's Interest Expenses at $26.6 million in Q1 2026, $3.3 million in Q4 2025, and $13.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 26.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.60 Mn |
| Mar 31, 2026 | 26.60 Mn |
| Dec 31, 2025 | 3.27 Mn |
| Dec 31, 2025 | 3.27 Mn |
| Sep 30, 2025 | 13.39 Mn |
| Sep 30, 2025 | 13.39 Mn |
| Jun 30, 2025 | 26.30 Mn |
| Jun 30, 2025 | 26.30 Mn |
| Mar 31, 2025 | 26.30 Mn |
| Mar 31, 2025 | 26.30 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 17.46 Mn |
| Sep 30, 2024 | 17.46 Mn |
| Jun 30, 2024 | 25.80 Mn |
| Jun 30, 2024 | 25.80 Mn |
| Mar 31, 2024 | 25.80 Mn |
| Mar 31, 2024 | 25.80 Mn |
| Dec 31, 2023 | 169.25 Mn |
| Dec 31, 2023 | 169.25 Mn |